Curateq Clinches UK MHRA Nod—Dyrupeg Gets Injected into Approval List

Unknown Apr 02, 2026 450 Views

Aurobindo Pharma's biologics subsidiary, Curateq Biologics, has won a significant regulatory nod from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its biosimilar Dyrupeg—a pegylated filgrastim indicated to reduce the incidence of neutropenia in patients undergoi...